Definitive Contract 75N93025C00012
Award Date
2/1/25
Potential Completion Date
4/10/25
Potential Value
$1.5M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Qoolabs Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Carlsbad, CA 92008, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Qoolabs Inc., a self-certified small disadvantaged business, for the development of affinity reagents for the immune system of guinea pigs. The $300,000 firm-fixed-price contract was awarded under the SBIR program and has a completion date of June 30, 2021. Qoolabs Inc. is a corporate entity that has received over $4 million in prime...
This is a small business set-aside contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Qoolabs Inc., a woman-owned small disadvantaged business in California. The $300,000 firm-fixed-price contract is for the development of affinity reagents for the immune system of guinea pigs. Qoolabs Inc. has previously received over $4 million in prime federal contracts from HHS agencies like NIAID and NCI for research...
This is a $1,500,000.00 SBIR Phase II contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Qoolabs Inc., a small disadvantaged and woman-owned business located in Carlsbad, California.
The contract is for research and development of medical technologies related to infectious diseases, immunology, and COVID-19 detection, including the development of affinity reagents,...
This is a $300,000 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Qoolabs Inc., a small disadvantaged business located in Carlsbad, California. The contract is for research and development under the Small Business Innovation Research (SBIR) program, with a period of performance through September 2025. Qoolabs is developing medical technologies related to infectious diseases,...
This $600,000 definitive contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of San Diego, California. The contract is for SBIR Topic 107 to develop affinity reagents for the immune system of the golden hamster, in alignment with the original solicitation seeking Small Business Innovation Research proposals across technical topics within NIH and CDC. Work will be performed in San Diego through September 2024 under...
This definitive contract from the Department of Health and Human Services' National Institutes of Health and National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) is valued at $600,000 to Qoolabs Inc. for monoclonal antibodies research aligned with SBIR Topic 107. The solicitation sought Small Business Innovation Research (SBIR) proposals across technical topics within NIH Institutes and CDC Centers to develop medical technologies, diagnostics, vaccines, cell therapies and...
This is a $21,208,581.76 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services (HHS), to Quality Biological Inc., a self-certified small disadvantaged business. The contract has a total small business set-aside designation and an ultimate completion date of April 7, 2025.
Quality Biological Inc., through its Quality Biological, Inc. division, is a minority-owned...
This is a $25,374,525.00 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Quality Biological Inc., a minority-owned small disadvantaged business. The contract is set aside for small businesses and has an ultimate completion date of April 7, 2032.
The purpose of the contract is to support the production, procurement, storage, shipping, and maintenance of high-quality...
This $596,519 fixed-price federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Ampersand Biosciences LLC, a woman-owned small business. The contract is for the development of reagents to support immunologic analysis of non-mammalian and underrepresented mammalian models, such as ferrets and mice, under SBIR Topic 107. This aligns with NIAID's mission to conduct and support research to...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $210,338.00 firm fixed-price purchase order to Creative Biolabs Inc. for mouse antibody production services across Phases I through IV. The contract, which runs through September 22, 2025, does not have a set-aside designation. Creative Biolabs, a specialized biotechnology and pharmaceutical services provider, will deliver custom solutions...